The experimental antiviral pill for Covid-19 results appears to surpass those seen with Merck & Co Inc's pill, Molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for Covid-19 patients also at high risk of serious illness.
World News Nov 5, 2021, 8:50 PM IST
Neither company has made the complete trial data available. Pfizer's stock rose 13 per cent to $49.47, while Merck's lost 6 per cent to $84.69.
World News Nov 5, 2021, 5:21 PM IST
The pill works by interfering with the virus’ replication and prevents it from multiplying, keeping virus levels low in the body and therefore reducing the severity of the disease.
United Kingdom Nov 4, 2021, 5:50 PM IST
If the US Food and Drug Administration grants Merck an EUA for the pill, it would be the first oral antiviral for Covid-19.
United States Oct 12, 2021, 9:59 AM IST
World Health Organisation, European Medicines Agency and the US Food and Drug Administration do not endorse the use of Ivermectin for Covid treatment. What's more, even Merck -- the company that manufactures Ivermectin -- has said that the medicine is not meant for Covid-19 treatment.
Coronavirus May 13, 2021, 1:22 PM IST
A similar warning has also been issued by 'ivermectin' manufacturer MSD, or Merck & Co., Inc, whose statement Dr Swaminathan attached to her tweet.
World News May 11, 2021, 4:02 PM IST